End of Year Examination for Bachelor of Medicine and Bachelor of Surgery Date: .....can't say Time: 2 Hours Unit Title: Medical Biochemistry II Paper A (MBMB .
End of Year Examination for Bachelor of Medicine and Bachelor of Surgery Date: .....can't say Time: 2 Hours Unit Title: Medical Biochemistry II Paper A (MBMB ...) Section B: LAQs & SAQs - Understanding Disease Mechanisms: Integrated metabolism helps a doctor understand how metabolic pathways interact in different tissues, aiding in the recognition of systemic metabolic disorders like diabetes mellitus, obesity, and metabolic syndrome. - Clinical Decision Making: Enables better interpretation of laboratory results (e.g., glucose levels, lipid profiles) in the context of the body's overall metabolic state. - Pharmacological Insights: Understanding metabolic interrelationships helps doctors predict drug interactions and metabolic side effects, especially in diseases like liver failure or renal impairment. - Nutritional Management: Supports dietary planning in patients with chronic illnesses (e.g., advising low-carbohydrate diets in insulin resistance). - Emergency Care: Assists in acute cases such as diabetic ketoacidosis or lactic acidosis, where quick understanding of metabolic pathways is crucial. - Thermogenic Properties: Brown and beige fat have high mitochondrial density and express uncoupling protein 1 (UCP1), which dissipates energy as heat. This helps in increasing energy expenditure. - Weight Reduction: Activation of brown/beige fat promotes lipolysis and fat oxidation, leading to reduction in adipose tissue and body weight. - Improved Glucose Tolerance: These tissues increase glucose uptake and insulin sensitivity, thus improving glycemic control in diabetic patients. - Target for Therapy: Research is ongoing to identify drugs (like β3-adrenergic agonists or cold exposure mimetics) that stimulate brown/beige fat activity. - Metabolic Health: Enhances lipid clearance from blood, reducing risk of atherosclerosis and cardiovascular diseases linked to obesity and diabetes. - Integrated metabolism refers to the coordination of biochemical pathways across multiple organs and tissues to meet the energy and biosynthetic demands of the body. - Key metabolic organs include the liver, muscle, adipose tissue, brain, and kidneys . - Hormones such as insulin, glucagon, catecholamines, cortisol , and growth hormone play vital roles in maintaining metabolic balance. - During feeding, anabolic pathways are activated (e.g., glycogenesis, lipogenesis), while in fasting, catabolic pathways (e.g., glycogenolysis, gluconeogenesis, lipolysis) dominate. - Integration ensures efficient substrate allocation, energy conservation, and homeostasis , adapting to physiological states like rest, exercise, stress, or illness. - Serum enzyme levels serve as markers of hepatocellular injury or cholestasis. - Alanine aminotransferase (ALT): Highly specific to liver; elevation indicates hepatocyte injury. - Aspartate aminotransferase (AST): Less specific; also found in muscle and heart; ratio of AST/ALT may help differentiate alcoholic vs non-alcoholic liver disease. - Alkaline phosphatase (ALP): Elevated in bile duct obstruction and cholestatic liver diseases. - Gamma-glutamyl transferase (GGT): Supports cholestatic diagnosis and alcohol-induced damage. - Lactate dehydrogenase (LDH): Less specific but can suggest hepatocellular necrosis. - Monitoring enzyme trends over time helps assess disease severity, progression, and treatment response . - Correct Collection Technique: Use of sterile containers, avoiding hemolysis and contamination. - Labeling: Accurate patient identifiers, date and time of collection are essential. - Preservation: Certain tests (e.g., blood gases, hormones) require refrigeration or immediate analysis. - Transport: Samples must be sent promptly to the lab to prevent degradation or clotting. - Pre-analytical Variations: Diet, timing, and patient posture can affect results; clinicians must understand these. - Documentation: Proper record-keeping ensures traceability and supports legal and diagnostic accuracy. - Blood Glucose: Evaluates carbohydrate metabolism; used in diagnosis and monitoring of diabetes mellitus. - Serum Creatinine: Indicates kidney function; elevated levels suggest impaired glomerular filtration. - Serum Bilirubin: Detects liver function or hemolysis; distinguishes between direct and indirect causes of jaundice. - Serum Electrolytes (Na+, K+): Monitor hydration status, renal function, and heart rhythm stability. - The Van den Bergh test measures serum bilirubin using diazotized sulfanilic acid. - Direct (Conjugated) bilirubin: Reacts immediately (within 30 seconds) = direct positive reaction. - Indirect (Unconjugated) bilirubin: Requires alcohol as a solubilizer = indirect positive reaction. - Mixed reaction: Suggests hepatocellular jaundice. - Clinical Interpretation: Direct positive: Obstructive jaundice (post-hepatic). - Indirect positive: Hemolytic jaundice (pre-hepatic). - Mixed reaction: Hepatitis or intrahepatic obstruction. 1. Alanine Aminotransferase (ALT): - ALT is mainly found in the liver and is a key marker of hepatocellular injury. - It rises significantly in viral hepatitis, drug-induced liver damage, and non-alcoholic fatty liver disease. - Its specificity to the liver makes it useful for monitoring disease progression and treatment response. 2. Aspartate Aminotransferase (AST): - Present in liver, heart, skeletal muscle, and kidneys. - Elevated in myocardial infarction (MI), acute liver diseases, and muscle trauma. - When combined with ALT, the AST/ALT ratio helps differentiate alcoholic liver disease ( 2) from viral hepatitis (<1). 3. Amylase: - Produced by pancreas and salivary glands. - Serum levels rise in acute pancreatitis, mumps, and salivary gland inflammation. - Levels increase within hours of pancreatic injury and are useful for early diagnosis. 4. Creatine Kinase (CK): - Exists in three isoforms: CK-MB (heart), CK-MM (skeletal muscle), and CK-BB (brain). - CK-MB rises in myocardial infarction and is used to confirm cardiac muscle damage. - CK-MM increases in muscular dystrophies and trauma; CK is also used to monitor statin toxicity. 5. Alkaline Phosphatase (ALP): - When elevated, it is often assessed alongside gamma-glutamyl transferase (GGT) to confirm hepatic origin. - Found in liver (biliary tract), bones, placenta, and intestines. - Raised in bile duct obstruction, bone diseases like rickets, and during pregnancy. 1. Pyruvate: - Formed from glycolysis. - Can be converted into acetyl-CoA (aerobic conditions), lactate (anaerobic), or oxaloacetate (gluconeogenesis). - Also a precursor for alanine in amino acid metabolism. - Thus, it links carbohydrate, lipid, and protein pathways. 2. Acetyl-CoA: - Produced from pyruvate, fatty acid β-oxidation, and amino acid catabolism. - Enters the TCA cycle for ATP production, forms ketone bodies during starvation, and serves as a precursor for cholesterol and fatty acid synthesis. - A major hub connecting energy production and biosynthetic processes. 3. Glucose-6-Phosphate (G6P): - A key intermediate of glycolysis. - Enters glycogenesis for storage, the pentose phosphate pathway (PPP) for NADPH and ribose-5-phosphate, or continues through glycolysis for energy. - Connects glucose metabolism to anabolic and antioxidant pathways. 4. Oxaloacetate: - TCA cycle intermediate that combines with acetyl-CoA to form citrate. - Also a precursor for gluconeogenesis and transamination reactions. - Can convert to aspartate or malate, playing a key role in amino acid metabolism and the malate-aspartate shuttle. Cori Cycle (Lactic Acid Cycle): - Demonstrates cooperation between skeletal muscle and liver. - During anaerobic exercise, muscles convert glucose to lactate (via glycolysis). - Lactate is transported via blood to the liver, where it is converted back to glucose by gluconeogenesis. - This glucose is then returned to the muscles for energy production. - The cycle prevents lactic acid accumulation and supports glucose homeostasis, especially during fasting or intense exercise. 1. A